Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0288863 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Jun Xiong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, 518055, China. Hauptthemen laut MEDLINE: Propofol, Craniopharyngioma, Pituitary Neoplasms, Methyl Ethers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wu Jieping Medical Foundation of Special Funding Support.
Abstract (Originalsprache)
Objective
General anesthesia can disturb the hormone levels in surgical patients. Hormone deficiency is one of the major symptoms of craniopharyngioma (CP) in pediatric patients. The aim of this prospective randomized controlled clinical study is to evaluate whether propofol and sevoflurane influence the perioperative hormone levels in these patients and to determine which anesthesia technique causes less impact on hormone levels. Materials Sixty-four ASA I and II pediatric patients with CP undergoing elective neurosurgery were randomly divided into the sevoflurane group (S group, n = 32) and the propofol group (P group, n = 32). Anesthesia was maintained with sevoflurane and propofol until the end of the operation. Demographic information, operation information and hemodynamic variables were recorded. The levels of hormones were evaluated preoperatively as the baseline (T0), 1h after the beginning of the operation (T1), immediately at the end of the operation (T2) and 72 h postoperatively (T3).
Results
There were no significant differences in the two groups in terms of patients’ demographics and intraoperative information, such as operation duration, blood loss and transfusion volumes, and fluid infusion volume ( P >0.05). In both groups, compared to those at T0, the levels of TSH, FT3, TT3 and ACTH at T1, T2 and T3 were significantly lower. The levels of FSH, PRL and GH at T3 were also significantly lower ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, 518055, China.
- Department of Anesthesiology, Peking University Third Hospital, Beijing, 100191, China.
- Department of Anesthesiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, 650032, China.
- Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China.
ORCID-Profile: Jun Xiong, Yongxing Sun
Förderung
- Wu Jieping Medical Foundation of Special Funding Support
Zitieren
APA
Xiong, J., Wang, M., Gao, J., Zhou, Y., Pang, Y., & Sun, Y. (2023). Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial. PLOS ONE. https://doi.org/10.1371/journal.pone.0288863
Vancouver
Xiong J, Wang M, Gao J, Zhou Y, Pang Y, Sun Y. Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial. PLOS ONE. 2023. doi:10.1371/journal.pone.0288863
BibTeX
@article{Xiong2023,
author = {Xiong, Jun and Wang, Mengrui and Gao, Jie and Zhou, Yafen and Pang, Yanan and Sun, Yongxing},
title = {Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0288863}
}
EUVIMED